1. Home
  2. VTAK vs BBLG Comparison

VTAK vs BBLG Comparison

Compare VTAK & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$0.78

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

BBLG

Bone Biologics Corp

HOLD

Current Price

$1.42

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTAK
BBLG
Founded
2002
2004
Country
United States
United States
Employees
N/A
2
Industry
Medical/Dental Instruments
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
2.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
VTAK
BBLG
Price
$0.78
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.4M
40.3K
Earning Date
08-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
89.53
N/A
EPS
N/A
N/A
Revenue
$442,000.00
N/A
Revenue This Year
$1,170.33
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3057.14
N/A
52 Week Low
$0.15
$1.05
52 Week High
$4.31
$4.13

Technical Indicators

Market Signals
Indicator
VTAK
BBLG
Relative Strength Index (RSI) 38.84 58.17
Support Level N/A $1.39
Resistance Level $0.93 $1.54
Average True Range (ATR) 0.18 0.11
MACD -0.03 0.00
Stochastic Oscillator 0.01 62.50

Price Performance

Historical Comparison
VTAK
BBLG

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.

About BBLG Bone Biologics Corp

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Share on Social Networks: